Search

Zimmer Biomet Holdings Inc

Chiusa

SettoreSettore sanitario

100.57 1.07

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

98.58

Massimo

101.05

Metriche Chiave

By Trading Economics

Entrata

-39M

199M

Vendite

90M

2.2B

P/E

Media del settore

23.392

57.002

EPS

2.07

Rendimento da dividendi

0.99

Margine di Profitto

9.159

Dipendenti

17,000

EBITDA

-210M

328M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+5.74% upside

Dividendi

By Acuity

Rendimento da dividendi

Media del settore

0.99%

2.22%

Utili prossimi

4 nov 2026

Prossima data del Dividendo

30 ott 2026

Prossima data del' Ex Dividendo

29 set 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-112M

19B

Apertura precedente

99.5

Chiusura precedente

100.57

Notizie sul Sentiment di mercato

By Acuity

50%

50%

171 / 340 Classifica in Healthcare

Zimmer Biomet Holdings Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

13 ago 2026, 19:46 UTC

Shares of Zimmer Biomet Holdings are trading higher, remaining strong near the upper end of their one-month range amid positive broader market sentiment.

12 ago 2026, 23:21 UTC

Zimmer Biomet Holdings Inc. shares are roughly flat in after-market trading, remaining above their 20-day moving average and near the upper end of their one-month range.

11 ago 2026, 23:02 UTC

Zimmer Biomet Holdings Inc. shares are higher in after-market trading, moving within a range above its 20-day moving average and near a one-month high.

10 ago 2026, 19:56 UTC

Correlated Moves
News

Canaccord raised Zimmer Biomet's price target to $100 from $83, maintaining a Hold rating. Shares are higher since Friday's close amid market strength.

7 ago 2026, 19:46 UTC

News

Zimmer Biomet shares are lower today as Truist maintains a Hold rating but raises the price target to $106 amid cautious market conditions.

6 ago 2026, 19:52 UTC

News

Zimmer Biomet shares are lower today, despite price target increases from RBC, BMO, and Wells Fargo. This marks a shift from recent higher daily closes.

5 ago 2026, 23:02 UTC

News

Stifel raised the price target on Zimmer Biomet to $110 from $105, maintaining a Buy rating. Shares are higher in after-market trading.

4 ago 2026, 22:01 UTC

Zimmer Biomet Holdings Inc. shares are lower in after-market trading, continuing a trend of weakness despite earlier stability and trading above its 20-day moving average.

3 ago 2026, 23:11 UTC

Shares of Zimmer Biomet Holdings Inc. are lower in after-market hours, showing weakness despite earlier gains and remaining above their 20-day moving average.

31 lug 2026, 20:06 UTC

Correlated Moves

Zimmer Biomet Holdings Inc. shares are lower today, influenced by Stryker Corp's decline and broader market sentiment amid rising Treasury yields and inflation concerns.

30 lug 2026, 19:03 UTC

Zimmer Biomet Holdings Inc shares are lower today, breaking a trend of higher closes. Broader economic indicators may contribute to market uncertainty.

29 lug 2026, 17:46 UTC

Zimmer Biomet Holdings Inc shares are higher, continuing a positive trend since Tuesday's close. Broader market volatility is impacting sentiment amid rising oil prices.

28 lug 2026, 20:03 UTC

News
Social Media

UBS initiated coverage on Zimmer Biomet with a Buy rating and a $115 price target, supporting shares' advance during the current trading session.

27 lug 2026, 18:46 UTC

Correlated Moves

Zimmer Biomet Holdings Inc is advancing in Monday's session, supported by a broader rise in the medical devices sector amid declining crude oil prices.

24 lug 2026, 19:06 UTC

Correlated Moves

Zimmer Biomet Holdings is trading higher, benefiting from a pullback in crude oil prices and positive sentiment in the health care equipment sector.

23 lug 2026, 21:02 UTC

Zimmer Biomet Holdings Inc shares are lower in after-market hours. No specific news was identified to explain the price movement.

22 lug 2026, 18:36 UTC

Correlated Moves

Zimmer Biomet Holdings Inc reported first-quarter adjusted EPS of $1.08, below estimates. Shares are lower today amid broader sector declines and external market pressures.

20 lug 2026, 18:16 UTC

Zimmer Biomet Holdings Inc shares are lower amid unusual volatility and broader market concerns over rising yields and inflation fears linked to increasing oil prices.

Confronto tra pari

Modifica del prezzo

Zimmer Biomet Holdings Inc Previsione

Obiettivo di Prezzo

By TipRanks

5.74% in crescita

Previsioni per 12 mesi

Media 105.29 USD  5.74%

Alto 120 USD

Basso 93 USD

Basato su 17 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Zimmer Biomet Holdings Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

17 ratings

6

Acquista

11

Mantieni

0

Vendi

Sentiment

By Acuity

171 / 340 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Neutral

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings, Inc. is a global medical technology company. Its segments include Americas, EMEA, and Asia Pacific. The Company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; craniomaxillofacial and thoracic (CMFT) products; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its other product category primarily includes its robotic, surgical and bone cement products. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee, and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System, and G7 Acetabular System. Its S.E.T. product category includes sports medicine, biologics, foot and others.
help-icon Live chat